1414 related articles for article (PubMed ID: 9166452)
41. Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.
Chen RC; Chin MS; Ng AK; Feng Y; Neuberg D; Silver B; Pinkus GS; Stevenson MA; Mauch PM
J Clin Oncol; 2010 Jan; 28(1):136-41. PubMed ID: 19933914
[TBL] [Abstract][Full Text] [Related]
42. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
Henry-Amar M
J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
[TBL] [Abstract][Full Text] [Related]
43. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia.
Pui CH; Cheng C; Leung W; Rai SN; Rivera GK; Sandlund JT; Ribeiro RC; Relling MV; Kun LE; Evans WE; Hudson MM
N Engl J Med; 2003 Aug; 349(7):640-9. PubMed ID: 12917300
[TBL] [Abstract][Full Text] [Related]
44. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.
Pedersen-Bjergaard J; Larsen SO
N Engl J Med; 1982 Oct; 307(16):965-71. PubMed ID: 7110299
[TBL] [Abstract][Full Text] [Related]
45. Acute leukemia after the treatment of Hodgkin's disease.
Henry-Amar M; Dietrich PY
Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
[TBL] [Abstract][Full Text] [Related]
46. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voƻte PA; Morris-Jones P; Greenberg M
Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
[TBL] [Abstract][Full Text] [Related]
47. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
[TBL] [Abstract][Full Text] [Related]
48. Second malignancies following treatment for Hodgkin's disease: a Greek experience.
Economopoulos T; Stathakis N; Alexopoulos C; Pavlidis N; Constantinidou M; Briassoulis E; Papageorgiou E; Dervenoulas J; Pappa V; Vaslamatzis M
Haematologica; 1994; 79(3):273-6. PubMed ID: 7926979
[TBL] [Abstract][Full Text] [Related]
49. Leukemia following Hodgkin's disease.
Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
[TBL] [Abstract][Full Text] [Related]
50. Increased mortality after successful treatment for Hodgkin's disease.
Hudson MM; Poquette CA; Lee J; Greenwald CA; Shah A; Luo X; Thompson EI; Wilimas JA; Kun LE; Crist WM
J Clin Oncol; 1998 Nov; 16(11):3592-600. PubMed ID: 9817280
[TBL] [Abstract][Full Text] [Related]
51. Long-term results of treatment of childhood and adolescent Hodgkin's disease in 73 patients: the experience of the Departments of Radiology and Hematology of the University of Rome "La Sapienza".
Enrici RM; Anselmo AP; Osti MF; Sbarbati S; Tombolini V; Cartoni C; Mandelli F; Biagini C
Haematologica; 1996; 81(3):245-52. PubMed ID: 8767530
[TBL] [Abstract][Full Text] [Related]
52. Hodgkin's and non-Hodgkin's lymphomas.
Hartge P; Devesa SS; Fraumeni JF
Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
[TBL] [Abstract][Full Text] [Related]
53. Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment.
Tukenova M; Diallo I; Hawkins M; Guibout C; Quiniou E; Pacquement H; Dhermain F; Shamsaldin A; Oberlin O; de Vathaire F
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):707-15. PubMed ID: 20200431
[TBL] [Abstract][Full Text] [Related]
54. Pathologic stage I and II Hodgkin's disease. Long-term results at three Connecticut hospitals.
Peschel RE; Hou-Wun Mai D; Dowling S; Knowlton A; Farber L; Fischer JJ
Conn Med; 1991 Aug; 55(8):449-52. PubMed ID: 1935066
[TBL] [Abstract][Full Text] [Related]
55. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease.
Henry-Amar M
NCI Monogr; 1988; (6):65-72. PubMed ID: 3352791
[TBL] [Abstract][Full Text] [Related]
56. Risk of second cancers after treatment for Hodgkin's disease.
Tucker MA; Coleman CN; Cox RS; Varghese A; Rosenberg SA
N Engl J Med; 1988 Jan; 318(2):76-81. PubMed ID: 3336397
[TBL] [Abstract][Full Text] [Related]
57. Survival of Danish cancer patients 1943-1987. Lymphatic and haematopoietic tissues.
Strom HH; Clemmensen IH
APMIS Suppl; 1993; 33():183-213. PubMed ID: 8512739
[TBL] [Abstract][Full Text] [Related]
58. Hodgkin's disease in childhood: treatment modalities, outcome and epidemiological aspects. The Northern Israel Cancer Center experience.
Rosenthal J; Ben Arush MW; Kuten A; Ben Arie J; Ben Shahar M; Robinson E
Am J Pediatr Hematol Oncol; 1994 May; 16(2):138-42. PubMed ID: 8166366
[TBL] [Abstract][Full Text] [Related]
59. Hodgkin's disease in Denmark. A national clinical study by the Danish Hodgkin Study Group, LYGRA.
Scand J Haematol; 1980 Apr; 24(4):321-34. PubMed ID: 6932097
[TBL] [Abstract][Full Text] [Related]
60. Late relapse after treatment for clinical stage I and II Hodgkin's disease.
Brierley JD; Rathmell AJ; Gospodarowicz MK; Sutcliffe SB; Pintillie M
Cancer; 1997 Apr; 79(7):1422-7. PubMed ID: 9083165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]